SecBot SecBot

NMRA

Neumora Therapeutics, Inc.
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. DE· CIK 0001885522 Biotech & Drug Discovery
$0.3700 −0.06 (−13.75%)
Nov 16 4:00 PM ET · prev $0.4290
Market cap
$81.4M
Micro cap
Median target
🔒 Subscribers only
1 year
−85.7%
from $2.59 · Nov 17
30 days
−21.3%
from $0.4700
52-week range
$0.3550–3.59
−90% from high · low Oct 14
Avg volume 20D
1.57M
Nov 2 spike 5.82M
Short interest
7.01M
≈3.7% of shares · +24.2%
Days to cover
5.1
at average volume
Insider net
−$701.6K
0 buyers · 1 seller · 12 mo
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
11
analyzed by SecBot
SecBot read BEARISH 5 reports · 90 days
Balance 2 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 1/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider sold $701.6K.

  • InstitutionsMIXED

    Q3 2026: 12 added (0 new), 13 trimmed or exited.

  • Short sellersBUILDING

    Short interest +24.2% to 7.01M shares. 5.1 days to cover, ≈3.7% of shares.

  • TrendRANGE

    36% below its 50-day average.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
FMR LLCTRIM2,604,191$1.6M
UBS Group AGDOUBLED961,702$573.2K
Qube Research & Technologies LtdDOUBLED952,055$567.6K
MARSHALL WACE, LLPTRIM330,514$198.3K
MORGAN STANLEYTRIM171,060$102.0K
JANE STREET GROUP, LLCTRIM139,208$83.0K
Squarepoint Ops LLCTRIM134,362$80.1K
BNP PARIBAS FINANCIAL MARKETSADD115,451$68.8K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Jul 2026

Fresh Price Targets

Analyst price targets updated within the last 24 hours are for subscribers only.

Subscribe for Full Access
Recent actions
DateFirmActionRating
Jul 13, 2026RBC Capital
MAINTAIN
MAINTAINOutperform
Jun 18, 2026Mizuho
MAINTAIN
MAINTAINOutperform
Jun 16, 2026Needham
MAINTAIN
MAINTAINBuy
Jun 16, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$0
bought · 0 insiders
$701.6K
sold · 1 insider
DateInsiderTypeValue
Aug 21, 2026
Aurora Daljit Singh
See Remarks
Aug 21, 2026
EXERCISE$14.8K
Aug 21, 2026
Aurora Daljit Singh
See Remarks
Aug 21, 2026
SELL$32.8K
Aug 21, 2026
Aurora Daljit Singh
See Remarks
Aug 21, 2026
EXERCISE$15.2K
Aug 21, 2026
Aurora Daljit Singh
See Remarks
Aug 21, 2026
SELL$33.6K
Aug 20, 2026
Pinto Joshua
President & CEO
Aug 20, 2026
AWARD500,000 sh
Aug 20, 2026
Milligan Michael Lee
See Remarks
Aug 20, 2026
AWARD175,000 sh
Aug 20, 2026
Duncan Jason
See Remarks
Aug 20, 2026
AWARD375,000 sh
Aug 20, 2026
Aurora Daljit Singh
See Remarks
Aug 20, 2026
EXERCISE$48.8K

Earnings setup

Estimates

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next Q🔒 Fresh data, subscribers only
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

Short side

FINRA· Oct 30, 2026
7,006,355
shares short
+24.2%
vs prior settlement
5.1
days to cover
≈3.7%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 SEC
🔒 Fresh report (last 24h), subscribers only
Nov 16, 2026 Earnings
🔒 Fresh data, subscribers only
Oct 30, 2026 SEC
Neumora Therapeutics received a Nasdaq deficiency notice for failing to maintain the $1.00 minimum bid price on the…
8-K · Impact 7/10
Sep 30, 2026 Inst.
FMR LLC · TRIM
2,604,191 shares ($1.6M)
Sep 30, 2026 Inst.
UBS Group AG · DOUBLED
961,702 shares ($573.2K)
Aug 21, 2026 Insider
Aurora Daljit Singh acquired via exercise 20,553 shares
See Remarks @ $0.7200 ($14.8K)
Aug 21, 2026 Insider
Aurora Daljit Singh sold 20,553 shares
See Remarks @ $1.59 ($32.8K)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
3 drugs tracked · Drug pipeline →
Recent

SecBot reports

11 filings · 3 press releases · 1 bullish · 4 bearish · 6 neutral
All NMRA filing & press-release reports (14)